You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 299 No. 22, June 11, 2008 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Commentary
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Topic Collections
 •Genetic Counseling/ Testing/ Therapy
 •Bacterial Infections
 •Alert me on articles by topic

Biofilms and Chronic Infections

Randall D. Wolcott, MD; Garth D. Ehrlich, PhD

JAMA. 2008;299(22):2682-2684.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

The prevailing paradigm of infectious disease is based on the work of Koch and colleagues, who more than 150 years ago isolated individual strains of bacteria and developed the pure culture method that is still used today. That work enlightened medicine by firmly establishing the germ theory of transmissible diseases and demonstrated that diseases like dysentery, tuberculosis, and anthrax are caused by microbiological agents.1 Hence, the field of microbiology developed around Koch's methods with clinical microbiologists working overwhelmingly with pure log-phase cultures in nutrient-rich media because this approach provided such a powerful tool for the study of acute epidemic bacterial diseases. However, this approach that examines only planktonic bacteria (free-floating, single cell phenotype) may have limited development of a more thorough understanding of microbial processes. In most natural environments and in chronic bacterial infections, the planktonic phenotype generally exists only transiently, and . . . [Full Text of this Article]

What Is a Biofilm?

Author Affiliations: Medical Biofilm Research Institute, Lubbock, Texas (Dr Wolcott); and Center for Genomic Sciences, Allegheny Singer Research Institute, Allegheny General Hospital, and Departments of Microbiology and Immunology, and Otolaryngology–Head and Neck Surgery, Drexel College of Medicine, Allegheny Campus, Pittsburgh, Pennsylvania (Dr Ehrlich).







HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2008 American Medical Association. All Rights Reserved.